Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update
April 22, 2019 08:00 ET
|
Adynxx, Inc.
Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on...
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
April 11, 2019 16:49 ET
|
Alliqua BioMedical, Inc
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of...
Alliqua Biomedical CEO Provides Update to Shareholders
January 03, 2019 07:00 ET
|
Alliqua BioMedical, Inc
LANGHORNE, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- To our Alliqua Shareholders: I hope you have seen our recent exciting announcements that we believe drove the increase in our market...
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies
November 28, 2018 07:30 ET
|
Alliqua BioMedical, Inc
LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today...
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
October 12, 2018 07:00 ET
|
Alliqua BioMedical, Inc
LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they...
Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc.
May 07, 2018 16:15 ET
|
Alliqua BioMedical, Inc
Alliqua to return capital to shareholders Alliqua Retains H.C. Wainwright and Co. to evaluate strategic options LANGHORNE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc....
Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
January 05, 2018 16:30 ET
|
Alliqua BioMedical, Inc
YARDLEY, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding...
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
November 09, 2017 07:02 ET
|
Alliqua BioMedical, Inc
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding...
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
November 09, 2017 07:01 ET
|
Alliqua BioMedical, Inc
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding...
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th
October 30, 2017 16:05 ET
|
Alliqua BioMedical, Inc
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative medicine company committed to restoring tissue and rebuilding...